Search

Your search keyword '"Durmo, R"' showing total 50 results

Search Constraints

Start Over You searched for: Author "Durmo, R" Remove constraint Author: "Durmo, R"
50 results on '"Durmo, R"'

Search Results

1. POS0932 AORTIC INVOLVEMENT IN GCA: A MULTICENTER RETROSPECTIVE STUDY

4. End of induction [18F]FDG PET is prognostic for progression-free survival and overall survival in follicular lymphoma patients enrolled in the FOLL12 trial

5. Impact of COVID-19 on the imaging diagnosis of cardiac disease in Europe

6. Prevalence of interstitial pneumonia suggestive of COVID-19 at 18F-FDG PET/CT in oncological asymptomatic patients in a high prevalence country during pandemic period: a national multi-centric retrospective study

7. Prevalence of interstitial pneumonia suggestive of COVID-19 at 18F-FDG PET/CT in oncological asymptomatic patients in a high prevalence country during pandemic period: a national multi-centric retrospective study

8. Impact of COVID-19 on the imaging diagnosis of cardiac disease in Europe

9. COMBINED USE OF MINIMAL RESIDUAL DISEASE MONITORING AND FDG‐PET FOR OUTCOME PREDICTION IN FOLLICULAR LYMPHOMA: RESULTS FROM THE FONDAZIONE ITALIANA LINFOMI (FIL) FOLL12 TRIAL.

11. EARLY METABOLIC RESPONSE IN FOLLICULAR LYMPHOMA: A SUBSET ANALYSIS OF THE FOLL12 TRIAL BY THE FONDAZIONE ITALIANA LINFOMI (FIL)

12. Impact of COVID-19 Pandemic on Cardiovascular Testing in Asia: The IAEA INCAPS-COVID Study

13. Impact of COVID-19 Pandemic on Cardiovascular Testing in Asia

14. Prevalence of interstitial pneumonia suggestive of COVID-19 at 18F-FDG PET/CT in oncological asymptomatic patients in a high prevalence country during pandemic period: a national multi-centric retrospective study

18. Possible delayed diagnosis and treatment of metastatic differentiated thyroid cancer by adopting the 2015 ATA guidelines

19. Attenuation correction in myocardial perfusion imaging affects the assessment of infarct size in women with previous inferior infarct

20. The impact of spleen metabolic tumor volume on total metabolic tumor volume and prognosis in patients with follicular lymphoma enrolled in FOLL 12 trial.

21. A gene expression signature to predict disease progression for Hodgkin Lymphoma patients who achieve a complete metabolic response after 2 ABVD courses.

22. Prognostic value of the end of induction PET in patients with follicular lymphoma: results from the analysis of FOLL 12 trial.

23. Possible delayed diagnosis and treatment of metastatic differentiated thyroid cancer by adopting the 2015 ATA guidelines

24. Impact of COVID-19 Pandemic on Cardiovascular Testing in Asia

25. Attenuation correction in myocardial perfusion imaging affects the assessment of infarct size in women with previous inferior infarct

26. Lymphoma: The Added Value of Radiomics, Volumes and Global Disease Assessment.

27. End of induction [ 18 F]FDG PET is prognostic for progression-free survival and overall survival in follicular lymphoma patients enrolled in the FOLL12 trial.

28. Treatment of giant cell arteritis with ultra-short glucocorticoids and tocilizumab: results from the extension of the TOPAZIO study.

29. Prevalence and distribution of vascular calcifications at CT scan in patients with and without large vessel vasculitis: a matched cross-sectional study.

30. The diagnostic and prognostic role of combined [ 18 F]FDG and [ 68 Ga]-DOTA-peptides PET/CT in primary pulmonary carcinoids: a multicentric experience.

31. Prognostic value of lesion dissemination in doxorubicin, bleomycin, vinblastine, and dacarbazine-treated, interimPET-negative classical Hodgkin Lymphoma patients: A radio-genomic study.

32. Predictive and Prognostic Role of Pre-Therapy and Interim 68Ga-DOTATOC PET/CT Parameters in Metastatic Advanced Neuroendocrine Tumor Patients Treated with PRRT.

33. The prognostic power of 18F-FDG PET/CT extends to estimating systemic treatment response duration in metastatic castration-resistant prostate cancer (mCRPC) patients.

34. Comparison between N 13 NH 3 -PET and 99m Tc-Tetrofosmin-CZT SPECT in the evaluation of absolute myocardial blood flow and flow reserve.

35. Cardiac amyloidosis incidentally detected by 18F-FDG PET/CT.

36. Improvement of diagnostic accuracy of 18fluorine-fluorodeoxyglucose PET/computed tomography in detection of infective endocarditis using a 72-h low carbs protocol.

37. Three years' clinical practice of Radium-223 therapy in patients with symptomatic bone metastases from metastatic castrate-resistant prostate cancer: a single-centre experience.

38. Efficacy of low radioiodine activity versus intermediate-high activity in the ablation of low-risk differentiated thyroid cancer.

39. 18 F-FDG PET/CT or PET Role in MALT Lymphoma: An Open Issue not Yet Solved-A Critical Review.

40. Nonfunctioning paraganglioma incidentally detected by 18 F-FDG PET/CT and confirmed by 123 I-MIBG M scintigraphy.

41. The Role of 18F-FDG PET/CT in Staging and Prognostication of Mantle Cell Lymphoma: An Italian Multicentric Study.

42. Encrusted cystitis detected by 18 F-FDG PET/CT.

43. 18 F-FDG PET/CT brown fat detection: Differences between adult and pediatric population in a 12 year experience.

44. 68 Ga-PSMA PET thyroid incidentalomas.

45. Radioguided lung lesion localization: introducing a fluoroscopy system in a SPECT/CT scan.

46. Thyroid metastasis from breast cancer detected by 18F-FDG PET/CT.

47. 18F-choline PET/CT incidental thyroid uptake in patients studied for prostate cancer.

48. Clinical and prognostic role of detection timing of distant metastases in patients with differentiated thyroid cancer.

49. Possible delayed diagnosis and treatment of metastatic differentiated thyroid cancer by adopting the 2015 ATA guidelines.

50. Attenuation correction in myocardial perfusion imaging affects the assessment of infarct size in women with previous inferior infarct.

Catalog

Books, media, physical & digital resources